LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials

<b>Objective:</b> To compare the inhibition of LAG3-PD1 versus the inhibition of CTLA-4-PD1 in patients with previously untreated advanced melanoma. <b>Methods:</b> The individual participant data (IPD) were extracted from the KM plots using a graphical reconstructive algorit...

Full description

Bibliographic Details
Main Authors: Bai-Wei Zhao, Fei-Yang Zhang, Yun Wang, Guo-Ming Chen, Man Nie, Zhou-Kai Zhao, Xiao-Jiang Chen, Kai-Ming Jiang, Run-Cong Nie, Ying-Bo Chen
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
PD-1
CTLA4
LAG3
melanoma
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/20/4975

Internet

https://www.mdpi.com/2072-6694/14/20/4975

Similar Items